Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2012
12/04/2012US8323658 Infectious bursal disease virus antigenic isolates and vaccines
12/04/2012US8323656 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
12/04/2012US8323655 Identification of antigenic peptides from multiple myeloma cells
12/04/2012US8323654 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
12/04/2012US8323653 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
12/04/2012US8323652 Antibodies against GPIbα
12/04/2012US8323651 Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
12/04/2012US8323650 Method of treating lewis Y-expressing tumors
12/04/2012US8323649 Antibodies to IL-6 and use thereof
12/04/2012US8323648 Methods of modulating and identifying agents that modulate intracellular calcium
12/04/2012US8323647 Humanized antibodies against the β-amyloid peptide
12/04/2012US8323646 Engineered anti-IL-13 antibodies, compositions, methods and uses
12/04/2012US8323645 Antibodies that bind OV064 and methods of use therefor
12/04/2012US8323644 Therapy-enhancing glucan
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012US8323615 Methods of processing multi-phasic dispersions
12/04/2012CA2626120C Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
12/04/2012CA2566409C Neisseria meningitidis igtb lipo-oligo-saccharides as adjuvant
12/04/2012CA2532966C Igm production by transformed cells and methods for quantifying said igm production
12/04/2012CA2525139C Cd20 binding molecules
12/04/2012CA2524939C Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
12/04/2012CA2495570C Immunostimulatory compositions and methods of stimulating an immune response
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2428834C Biodegradable poly(beta-amino esters) and uses thereof
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2371714C Streptococcus pneumoniae proteins and vaccines
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
12/04/2012CA2340304C Multicomponent vaccines
12/04/2012CA2261630C Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease
12/04/2012CA2222509C Connective tissue growth factor
12/04/2012CA2210484C Composition to ameliorate osteolysis and metastasis
11/2012
11/29/2012WO2012162637A2 Vaccine adjuvants from self-assembling peptides
11/29/2012WO2012162629A2 Popcorn shape gold nanoparticle for targeted diagnosis, photothermal treatment and in-situ monitoring therapy response for cancer and multiple drug resistance bacteria
11/29/2012WO2012162620A1 Modulated immunodominance therapy
11/29/2012WO2012162583A1 Design and construction of novel multivalent antibodies
11/29/2012WO2012162565A2 Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
11/29/2012WO2012162564A1 Method for inducing an immune response and formulations thereof
11/29/2012WO2012162428A1 Prime-boost vaccination for viral infection
11/29/2012WO2012162426A1 Methods and compositions for heptameric targeting ligands
11/29/2012WO2012162418A1 Methods and compositions for heterodimeric targeting ligands
11/29/2012WO2012162394A2 Compositions and methods for treating renal disease
11/29/2012WO2012162367A1 Methods of treating systemic lupus erythematosus, scleroderma, and myositis with an antibody against interferon-alpha
11/29/2012WO2012162342A2 Influenza vaccines containing modified adenovirus vectors
11/29/2012WO2012162257A2 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/29/2012WO2012162253A2 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
11/29/2012WO2012162243A2 Anti-cgrp compositions and use thereof
11/29/2012WO2012162137A1 Hepatitis c virus particles, vaccines, compositions and methods related thereto
11/29/2012WO2012162068A2 Deimmunized serum-binding domains and their use for extending serum half-life
11/29/2012WO2012162067A2 Cd3-binding molecules capable of binding to human and non-human cd3
11/29/2012WO2012161856A1 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
11/29/2012WO2012161755A2 Antagonism of the vip signaling pathway
11/29/2012WO2012161372A1 Double-target antibody fused with a peptide and use of same
11/29/2012WO2012160448A2 Anti-kir antibodies for the treatment of inflammatory disorders
11/29/2012WO2012160200A1 Tolerogenic dendritic cells and their use in cell therapy
11/29/2012WO2012160199A1 Inactivated dengue virus vaccine
11/29/2012WO2012160184A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160183A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160153A1 Agents for treating tumours
11/29/2012WO2012159562A1 Truncated human papillomavirus type 33 protein l1
11/29/2012WO2012159522A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/29/2012WO2012139099A3 Herpes simplex virus vaccine
11/29/2012WO2012139094A3 Method of developing a vaccine using peptide-poly ic complexes
11/29/2012WO2012139081A3 Methods for treating conditions associated with masp-2 dependent complement activation
11/29/2012WO2012138836A3 Attenuated live vaccines for aquatic animals
11/29/2012WO2012137071A3 Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
11/29/2012WO2012136534A3 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
11/29/2012WO2012127289A8 R2r1/2 in diagnosis and therapy
11/29/2012WO2012125623A3 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
11/29/2012WO2012106670A8 Expandable liquid volume in an led bulb
11/29/2012WO2012102521A3 Human anti-cd23 fab antibody and a pharmaceutical composition for treating tumours comprising same
11/29/2012WO2011104315A3 Immunoglobulin preparation and storage system for an immunoglobulin preparation
11/29/2012WO2011032108A3 Formulation for room temperature stabilization of a live attenuated bacterial vaccine
11/29/2012US20120304319 Tox3 as a biomarker for breast cancer
11/29/2012US20120302816 Therapeutic compositions and methods for targeted delivery of active agents
11/29/2012US20120302739 Biological products
11/29/2012US20120302729 Anticancer anti-mortalin peptide antibody
11/29/2012US20120302627 Method of using adenoviral vectors to induce an immune response
11/29/2012US20120302452 Comparative ligand mapping from mhc class i positive cells
11/29/2012US20120301959 Cryoconserved Mature Dendritic Cells
11/29/2012US20120301871 Comparative ligand mapping from mhc positive cells
11/29/2012US20120301540 Method of treatment for bladder dysfunction
11/29/2012US20120301534 Method for lowering feed conversion rate
11/29/2012US20120301510 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/29/2012US20120301504 Influenza Virus Recombinant Proteins
11/29/2012US20120301503 Influenza hemagglutinin and neuraminidase variants
11/29/2012US20120301502 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
11/29/2012US20120301501 Method for selecting and producing vaccine components and vaccines based thereon
11/29/2012US20120301500 Anti-sepsis conjugate vaccine
11/29/2012US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use
11/29/2012US20120301498 Controlled release of immunosuppressants from synthetic nanocarriers
11/29/2012US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301495 Antigen peptide and use thereof
11/29/2012US20120301494 Proteolysis-resistant capsid of chimeric hepatitis e virus as an oral delivery vector
11/29/2012US20120301493 Applications of the protein muns and the derivates thereof
11/29/2012US20120301492 Compositions and methods for wt1 specific immunotherapy
11/29/2012US20120301491 Use of Modified Extracellular Matrix Proteins in Diagnosis and Treatment of Atherosclerosis
11/29/2012US20120301490 Immunoconjugates, compositions for making them, and methods of making and use
11/29/2012US20120301489 Jagged-Binding Agents and Uses Thereof
11/29/2012US20120301488 Anti-cd40 antibodies and methods of use
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 1823